IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,325 | +18.0% | 216,782 | +23.3% | 0.13% | -5.8% |
| Q4 2022 | $1,123 | -99.9% | 175,793 | +117.6% | 0.14% | +35.0% |
| Q3 2022 | $774,000 | -60.8% | 80,776 | -54.8% | 0.10% | -65.2% |
| Q2 2022 | $1,972,000 | +604.3% | 178,578 | +961.5% | 0.30% | +678.9% |
| Q1 2022 | $280,000 | -4.8% | 16,823 | +9.3% | 0.04% | +2.7% |
| Q4 2021 | $294,000 | +19.0% | 15,398 | +189.4% | 0.04% | -7.5% |
| Q4 2020 | $247,000 | +81.6% | 5,321 | -62.7% | 0.04% | +185.7% |
| Q1 2019 | $136,000 | -43.1% | 14,266 | -47.2% | 0.01% | -50.0% |
| Q4 2018 | $239,000 | – | 27,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |